Abstract 1739: Intratumoral INTASYL™ self-delivering RNAi targeting PD-1 provides in vivo tumor control and mechanistic modulation of tumor microenvironment analogous to that of systemic anti-PD-1 antibody

Authors: Benjamin Cuiffo, Melissa Maxwell, Dingxue Yan, James Cardia, Simon P. Fricker

Published: 2021-07-01

DOI: 10.1158/1538-7445.am2021-1739

Source: Full article